Cardiovascular Diseases

NOACs Safer in AF with Prior ICH

A cohort study in Taiwan suggested that among patients with atrial fibrillation (AF) with prior ICH, non–vitamin K antagonist oral anticoagulants (NOACs) use was associated with lower rates of intracranial hemorrhage (ICH) and major bleeding compared with warfarin use, whereas the rate of ischemic stroke was similar. The study included 4540 patients (mean age, 76.0 years; 58.4% men), with 1047 patients receiving warfarin (mean age, 75.1 years; 54.5% men) and 3493 patients receiving NOACs (mean age, 76.3 years; 59.6% men). Compared with warfarin use, NOACs use was associated with statistically significantly lower risk of all-cause mortality (adjusted hazard ratio [aHR], 0.517), ICH (aHR, 0.556), and major bleeding (aHR, 0.645), whereas the rate of ischemic stroke was similar in the 2 groups (aHR, 0.879). The results were generally consistent after propensity score matching among 973 patients in each group. The findings suggest that NOACs could be the preferred choice for stroke prevention in AF patients with prior ICH. Source: https://zh.jamanetwork.com/

hyangiu

Recent Posts

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

1 day ago

Faster Walking Pace May Reduce Risk of Cardiac Arrhythmias

A prospective UK cohort study found that both self-reported average or brisk walking pace and…

1 day ago

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

4 weeks ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

1 month ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

1 month ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

1 month ago

This website uses cookies.